Article ID Journal Published Year Pages File Type
5611625 Journal of the American Society of Echocardiography 2008 7 Pages PDF
Abstract
The combination of a newer quantitative echocardiographic technique (SR analysis) and a newer pharmacologic agent (levosimendan) improves the sensitivity of viability assessment compared with conventional dobutamine echocardiography.
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , , , , , ,